# Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure

> **NCT05236673** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 610 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** JARDIANCE®

## Key facts

- **NCT ID:** NCT05236673
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-28
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 610 (ACTUAL)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05236673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05236673, "Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05236673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*